Sentences with phrase «translational cancer research at»

Not exact matches

But Mohler, senior vice president for Translational Research at Roswell Park Cancer Institute, responded that Albany needs to have a greater sense of urgency.

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cCancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cancercancer.

Professor Paolo Boffetta (MD), the Annals of Oncology associate editor for epidemiology and Director of the Institute of Translational Epidemiology at the Icahn School of Medicine at Mount Sinai in New York (USA), commented: «These results are extremely important in showing that reducing cancer mortality can be achieved: priority should be given to research in cancers with unfavourable trends, such as pancreatic cancer, and in reducing cancer mortality disparities, both between countries (Central / Eastern versus Western Europe), and within countries, for example, between socioeconomic groups.

My next career step was to accept a 6 - month position, which was then extended by an additional year, to establish a translational research laboratory for cancer immunotherapy at the Gustave Roussy Cancer Campus, a major nonprofit health care, research, and teaching institution in cancer immunotherapy at the Gustave Roussy Cancer Campus, a major nonprofit health care, research, and teaching institution in Cancer Campus, a major nonprofit health care, research, and teaching institution in Paris.

The lab of co-author Dr. Robert Bast Jr., an expert in ovarian cancer and vice president for translational research at MD Anderson, inserted gel - bound carbon nanotubes into the ovaries of rodents to mimic the accumulations that are expected for nanotubes linked to special antibodies that recognize tumor cells.

«The exciting research results being presented today underscore how transplants are becoming an increasingly successful treatment option for more patients with blood cancer than ever before,» said Jeffrey Miller, MD, moderator of the press conference and Deputy Director of the Masonic Cancer Center and the Clinical and Translational Sciences Institute at the University of Minnesota in Minneacancer than ever before,» said Jeffrey Miller, MD, moderator of the press conference and Deputy Director of the Masonic Cancer Center and the Clinical and Translational Sciences Institute at the University of Minnesota in MinneaCancer Center and the Clinical and Translational Sciences Institute at the University of Minnesota in Minneapolis.

«AML is a disease in which fewer than 30 percent of patients are cured,» said co-senior author Ulrich Steidl, M.D., Ph.D., associate professor of cell biology and of medicine and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research at Einstein and associate chair for translational research in oncology at MonResearch at Einstein and associate chair for translational research in oncology at Monresearch in oncology at Montefiore.

The results of the study were published this week in the journal Nature Medicine from researchers at Penn's Abramson Cancer Center, including senior author Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in the ACC, the University of Maryland School of Medicine, and Adaptimmune Therapeutics plc (Adaptimmune).

«High dose steroids is the only proven treatment for GVHD,» said James L. M. Ferrara, MD, DSc, Ward - Coleman Chair in Cancer Medicine Professor at the Icahn School of Medicine at Mount Sinai, Director of Hematologic Malignancies Translational Research Center at Tisch Cancer Institute at Mount Sinai.

«It's a dramatic increase in lifespan of animal models, as much as 25 percent,» said Leyuan Liu, PhD, assistant professor at the Texas A&M Institute of Biosciences and Technology's Center for Translational Cancer Research.

The researchers, led by Professor Bernd Pichler at the Werner Siemens Imaging Center, worked with dermatologists, pathologists and immunologists at the University hospitals and at the German Consortium for Translational Cancer Research.

What we are changing is the amount of time that the formulation needs to be there, because we're accelerating how the drug enters the tissue,» says Giovanni Traverso, a research affiliate at MIT's Koch Institute for Integrative Cancer Research, a gastroenterologist at MGH, and one of the senior authors of a paper describing the technique in the Oct. 21 issue of Science Translational Mresearch affiliate at MIT's Koch Institute for Integrative Cancer Research, a gastroenterologist at MGH, and one of the senior authors of a paper describing the technique in the Oct. 21 issue of Science Translational MResearch, a gastroenterologist at MGH, and one of the senior authors of a paper describing the technique in the Oct. 21 issue of Science Translational Medicine.

Mass General geneticist Dora Dias - Santagata explains that she and other pathologists at the hospital's Translational Research Laboratory examine patients» tumors for more than 150 cancer - inducing mutations.

The effort is the fruit of a new model of translational research being pursued at the Wyss Institute for Biologically Inspired Engineering at Harvard University that integrates the latest cancer research with bioinspired technology development.

«An important translational implication of this research is that we hope that by combining Notch inhibitors with drugs that target B - cell signaling we can better treat these B - cell cancers,» said senior author Warren Pear, MD, PhD, a professor of Pathology and Laboratory Medicine at Penn Medicine.

Following his postdoctoral training at the INSERM U. 311 in Strasbourg, France and the Cancer Genetics Branch at the National Human Genome Research Institute in Bethesda, Maryland, Dr. Azorsa joined the Translational Genomics Research Institute (TGen) based in Phoenix, Arizona.

February 10, 2006 $ 25 million gift from Jules and Gwen Knapp will help build 10 - story medical research facility at the University of Chicago Jules and Gwen Knapp of Chicago have donated $ 25 million toward construction of a 330,760 - square - foot, 10 - story, state - of - the - art facility that will provide a new home for translational research programs in children's health, cancer, and other medical specialties at the University of Chicago.

«Pin1 changes protein shape through proline - directed phosphorylation, which is a major control mechanism for disease,» explains co-senior author Kun Ping Lu, MD, PhD, Director of Translational Therapeutics in the Cancer Research Institute at BIDMC and Professor of Medicine at Harvard Medical School who co-discovered the enzyme in 1996.

The goal of the Center for Clinical and Translational Sciences (CCTS) is to facilitate clinical and translational research at UTHealth, The University of Texas MD Anderson Cancer Center and the Memorial Hermann HosTranslational Sciences (CCTS) is to facilitate clinical and translational research at UTHealth, The University of Texas MD Anderson Cancer Center and the Memorial Hermann Hostranslational research at UTHealth, The University of Texas MD Anderson Cancer Center and the Memorial Hermann Hospital System.

«RNAi therapies are a unique approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.&cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.&cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.&Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.&cancer cell to block the expression of specific proteins involved in tumor growth.»

The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of HCancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Hcancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of HCancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes ofResearch Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes ofresearch at GUMC including a Clinical and Translational Science Award from the National Institutes of Health.

At the dinner, Parker also received the organization's highest honor for lay individuals, the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research, for his outspoken endorsement of cancer immunotherapy and substantial financial support of the Cancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strongCancer Research, for his outspoken endorsement of cancer immunotherapy and substantial financial support of the Cancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strongcancer immunotherapy and substantial financial support of the Cancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strongCancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strongCancer, an organization to which Parker has strong ties.

Andre Goy, MD, MS Chairman and Director, Chief of Lymphoma Director, Clinical and Translational Cancer Research John Theurer Cancer Center at Hackensack University Hackensack Meridian Health Professor of Medicine, Georgetown University Hackensack, NJ

The work was supported by the Salk Institute's Dulbecco Center for Cancer Research, the Adler Family Foundation, the Ahmanson Translational Imaging Division at UCLA, the National Center for Advancing Translational Sciences, the National Institutes of Health, the American Cancer Society, the Samuel Waxman Cancer Research Foundation, the Howard Hughes Medical Institute and the Leona M. and Harry B. Helmsley Charitable Trust.

Dr. Melinda Biernacki, a senior hematology - oncology fellow at Fred Hutch Cancer Research Center, has been selected to participate in the 2016 Translational Research Training in Hematology, or TRTH, a joint program sponsored by the American Society of Hematology, or ASH, and the European Hematology Association.

Together, this translational program is developed within the National Cancer and Cognition Platform (CNO / Ligue Nationale contre le cancer), with the aim to collaborate in a structured way with French oncology groups, research teams as well as pharmaceutical industry, by providing preclinical models and guidance on standard operating procedures for ancillary or future studies in identified population atCancer and Cognition Platform (CNO / Ligue Nationale contre le cancer), with the aim to collaborate in a structured way with French oncology groups, research teams as well as pharmaceutical industry, by providing preclinical models and guidance on standard operating procedures for ancillary or future studies in identified population atcancer), with the aim to collaborate in a structured way with French oncology groups, research teams as well as pharmaceutical industry, by providing preclinical models and guidance on standard operating procedures for ancillary or future studies in identified population at risk.

Dr. Carl H. June is the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine and the director of Translational Research at the Abramson Cancer Center at the University of Pennsylvania.

Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in cancer and their potential therapeutic manipulation.

The New Investigator Committee has a broad remit spanning basic and translational cancer research, responsible for a number of funding schemes to support the cancer research leaders of tomorrow at all stages of their careers.

This training program will consist of 14 months of clinical training at Northwell Health hospitals and ambulatory cancer center in Lake Success, NY, followed by two years of post-doctoral translational research training at Cold Spring Harbor Laboratory.

The NCTN represents «an unmatched effort to integrate and streamline the process of cancer clinical trials research,» said James Doroshow, MD, deputy director for clinical and translational research at NCI in a statement released by NCI last month.

MD Anderson's Institute for Applied Cancer Science (IACS) in combination with Deerfield will provide drug discovery and development expertise, together with translational research focused at advancing autophagy therapeutics into trials in melanoma, lung and pancreatic cancers.

The Divisions of Cancer Prevention (DCP) and Cancer Biology (DCB) at the National Institutes of Health (NIH) has awarded a $ 6 million grant to investigators at the University of Michigan to continue support for a Research Center in the Barrett's Esophagus Translational Research Network (BETRNet)-- this consortium studies the connection between Barrett's esophagus and risk for developing esophageal cCancer Prevention (DCP) and Cancer Biology (DCB) at the National Institutes of Health (NIH) has awarded a $ 6 million grant to investigators at the University of Michigan to continue support for a Research Center in the Barrett's Esophagus Translational Research Network (BETRNet)-- this consortium studies the connection between Barrett's esophagus and risk for developing esophageal cCancer Biology (DCB) at the National Institutes of Health (NIH) has awarded a $ 6 million grant to investigators at the University of Michigan to continue support for a Research Center in the Barrett's Esophagus Translational Research Network (BETRNet)-- this consortium studies the connection between Barrett's esophagus and risk for developing esophageal cancercancer.

Carl June is currently the director of the Translational Research Program at the Abramson Cancer Center at the University of Pennsylvania, and is an Investigator of the Abramson Family Cancer Research Institute.

Its membership is defined as the Associate Deans of Research from the Colleges, the Director of the Hollings Cancer Center, the Chief Research Informatics Officer, the Director of the South Carolina Clinical and Translational Research Institute, the Assistant Provost for Research Infrastructure, the Assistant Provost for Research Compliance and Regulatory Affairs, and two at - large members.

PRESENTERS: Philip Clifford, Ph.D., Associate Dean for Research at the College of Applied Health Sciences, Director of Mentoring for the UIC Center for Clinical and Translational Science, University of Illinois at Chicago; Brendan Delaney, J.D., Immigration Attorney, Frank & Delaney Immigration Law, LLC, Advisory Council member, NPA; Sina Safayi, D.V.M., Ph.D., Assistant Director of Career Development, Grad School, The University of Texas MD Anderson Cancer Center

At the Sidney Kimmel Comprehensive Cancer Center, Dr. Nelson has served as the Associate Director for Translational Research and the Co-Director of the Prostate Cancer Program, and acts in a leadership role for the National Cancer Institute - funded Howard University Cancer Center - Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns HopkinAt the Sidney Kimmel Comprehensive Cancer Center, Dr. Nelson has served as the Associate Director for Translational Research and the Co-Director of the Prostate Cancer Program, and acts in a leadership role for the National Cancer Institute - funded Howard University Cancer Center - Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns HoCancer Center, Dr. Nelson has served as the Associate Director for Translational Research and the Co-Director of the Prostate Cancer Program, and acts in a leadership role for the National Cancer Institute - funded Howard University Cancer Center - Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns Research and the Co-Director of the Prostate Cancer Program, and acts in a leadership role for the National Cancer Institute - funded Howard University Cancer Center - Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns HoCancer Program, and acts in a leadership role for the National Cancer Institute - funded Howard University Cancer Center - Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns HoCancer Institute - funded Howard University Cancer Center - Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns HoCancer Center - Sidney Kimmel Comprehensive Cancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns HoCancer Center Partnership Program, dedicated to building cancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns Hocancer research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns research capabilities at Howard and to enhancing minority subject recruitment to cancer - research programs at Johns Hopkinat Howard and to enhancing minority subject recruitment to cancer - research programs at Johns Hocancer - research programs at Johns research programs at Johns Hopkinat Johns Hopkins.

«The cancer care and research community at MSM has seen significant growth over the past five years; doubling the number of oncologists and quadrupling the amount of translational research funding.

Physician - scientists at the Cancer Institute engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life.

April 18, 2011 Cancer specialist Mark Ratain receives prestigious award from leading oncology society Mark Ratain, MD, the Leon O. Jacobson Professor of Medicine at the University of Chicago, has been awarded the Translational Research Professorship for 2011 by the American Society for Clinical Oncology's Conquer Cancer Foundation.

The ITCMS postdoctoral training program at the UNC Lineberger Comprehensive Cancer Center provides an exceptional interdisciplinary training experience, including outstanding basic and translational research opportunities with renowned investigators, and an extensive scope of workshops and training modules with an emphasis on cancer model syCancer Center provides an exceptional interdisciplinary training experience, including outstanding basic and translational research opportunities with renowned investigators, and an extensive scope of workshops and training modules with an emphasis on cancer model sycancer model systems.

At Roswell Park, along with his translational lab research, Dr. Koya leads an NIH funded prospective clinical trial based on an immune - modulator - enhanced TCR - engineered T cell transfer for metastatic cancer patients.

«Black women have been noted to present [at a doctor's office] with later stage cancer, which has a worse outcome — and they don't always get adequate care,» says Ruth ORegan, MD, associate professor of hematology and oncology and director of the translational breast cancer research program at Emory University's Winship Cancer Institute in Atcancer, which has a worse outcome — and they don't always get adequate care,» says Ruth ORegan, MD, associate professor of hematology and oncology and director of the translational breast cancer research program at Emory University's Winship Cancer Institute in Atcancer research program at Emory University's Winship Cancer Institute in AtCancer Institute in Atlanta.

Dr. Breen is a member of the NCSU Center for Comparative Medicine and Translational Research (CCMTR) and the Cancer Genetics Program at the University of North Carolina's Lineberger Comprehensive Cancer Center.

From 2001 - 2010 he was an Assistant Professor of Oncology at Cornell, where his research efforts were focused on clinical and translational projects involving cancer control and pharmacological validation of new agents.